• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: October 29-November 2, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

October 29-November 2, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
John M. Taylor, III, J.D., Counselor to the Commissioner10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Virginia Cox, Associate Commissioner for External Affairs10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Elizabeth H. Dickinson, Esq., Chief Counsel10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Jesse Goodman, M.D., M.P.H., Chief Scientist10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Walter Harris, Chief Operating Officer10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Jeanne Ireland, Associate Commissioner for Legislation10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Peter Lurie, Acting Associate Commissioner for Policy and Planning10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Melinda Plaiser, Acting Associate Commissioner for Regulatory Affairs10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health11/2/12Silver Spring, MDN/AMichele M. Schoonmaker (Cepheid)Meet and Greet 
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Mary Lou Valdez, Associate Commissioner for International Programs10/30/12-10/31/12Geneva, SwitzerlandDara CorriganN/A26th International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Assembly 
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs10/29/12-11/2/12N/AN/AN/ANo Significant Meetings 
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research10/29/12-11/2/12N/AN/AN/ANo Significant Meetings